Literature DB >> 1577975

Acquired factor XI inhibitor in chronic lymphocytic leukaemia.

M J Goodrick1, A G Prentice, J A Copplestone, D H Pamphilon, R J Boon.   

Abstract

A 71 year old man with chronic lymphocytic leukaemia (CLL) experienced excessive bleeding following transurethral resection of the prostate. Investigations showed a prolonged kaolin cephalin clotting time (KCCT) with low concentrations of factor XI. The prolonged KCCT was largely corrected by mixing with normal plasma but this correction was lost on incubation, confirming the presence of an inhibitor. He was treated with pulsed methylprednisolone and chlorambucil which resulted in the resolution of the bleeding problem and the loss of detectable circulating inhibitor.

Entities:  

Mesh:

Year:  1992        PMID: 1577975      PMCID: PMC495279          DOI: 10.1136/jcp.45.4.352

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  4 in total

1.  Naturally occurring human antibodies against two distinct functional domains in the heavy chain of FXI/FXIa.

Authors:  R A De La Cadena; F A Baglia; C A Johnson; R E Wenk; R Amernick; P N Walsh; R W Colman
Journal:  Blood       Date:  1988-11       Impact factor: 22.113

2.  Acquired factor XI inhibitors in congenitally deficient patients.

Authors:  S F Schnall; T P Duffy; L P Clyne
Journal:  Am J Hematol       Date:  1987-12       Impact factor: 10.047

3.  Transfusion-induced specific anti-factor XI inhibitor in a patient with previously unrecognized factor XI deficiency.

Authors:  C E Musclow; D Amato; F Ofosu; A L Armstrong; D Abbott
Journal:  Am J Clin Pathol       Date:  1988-03       Impact factor: 2.493

4.  A sensitive test demonstrating lupus anticoagulant and its behavioural patterns.

Authors:  T Exner; K A Rickard; H Kronenberg
Journal:  Br J Haematol       Date:  1978-09       Impact factor: 6.998

  4 in total
  4 in total

1.  Acquired inhibitors of clotting factors: AICE recommendations for diagnosis and management.

Authors:  Massimo Franchini; Giancarlo Castaman; Antonio Coppola; Cristina Santoro; Ezio Zanon; Giovanni Di Minno; Massimo Morfini; Elena Santagostino; Angiola Rocino
Journal:  Blood Transfus       Date:  2015-06-24       Impact factor: 3.443

2.  Intramural esophageal hematoma precipitated by acquired factor XI deficiency in a patient with relapsed T cell prolymphocytic leukemia after allogeneic hematopoietic cell transplantation.

Authors:  Naonori Harada; Yosuke Makuuchi; Masatomo Kuno; Teruhito Takakuwa; Hiroshi Okamura; Mitsutaka Nishimoto; Yasuhiro Nakashima; Hideo Koh; Masato Bingo; Akira Higashimori; Yasuhiro Fujiwara; Masayuki Hino; Hirohisa Nakamae
Journal:  Ann Hematol       Date:  2022-08-31       Impact factor: 4.030

3.  Acquired Factor XI Inhibitor Presenting as Spontaneous Bilateral Subdural Hematoma in an Elderly Patient.

Authors:  Natale Vazzana; Luca Scarti; Chiara Beltrame; Antonella Picchi; Gianni Taccetti; Alberto Fortini
Journal:  Case Rep Hematol       Date:  2014-11-06

4.  Acquired Factor XI Deficiency during SARS-CoV-2 Infection: Not Only Thrombosis.

Authors:  Giacomo Andreani; Lorenzo Uscello; Barbara Montaruli; Antonio Briozzo; Francesco Vitale; Marinella Tricarico; Luisa Arnaldi; Stefania Marengo; Claudio Norbiato
Journal:  TH Open       Date:  2020-09-13
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.